Haemonetics Corporation (HAE) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.55B |
| Enterprise Value | 3.53B |
| P/E Ratio | 35.55 |
| PEG Ratio | -0.92 |
| Price/Sales Ratio | 2.47 |
| Price/Book Ratio | 4.21 |
| Enterprise/Revenue | 3.2 |
| Enterprise/EBITDA | 15.26 |
| Fiscal Year | March 28, 2026 |
| Most Recent Quarter | March 28, 2026 |
| Profit Margin | 0.07 |
| Operating Margin | 0.18 |
| Return On Assets | 0.04 |
| Return On Equity | 0.11 |
| Revenue | 1.33B |
| Revenue/Share | 28.86 |
| Gross Profit | 743.59M |
| EBITDA | 312.45M |
| Net Income | 97.31M |
| Diluted EPS | 2.05 |
| Total Cash | 245.44M |
| Total Cash/Share | 5.31 |
| Total Debt | 1.22B |
| Total Debt/Equity | 1.54 |
| Current Ratio | 2.95 |
| Book Value Per Share | 17.23 |
| 52-Week Change | 0.64 |
| 52-Week High | 87.32 |
| 52-Week Low | 47.32 |
| Moving Average 50 Days | 63.66 |
| Moving Average 200 Days | 63.9 |
| Average Volume | 883,414 |
| Shares Outstanding | 45.45M |
| % Held by Institutions | 101.77 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | December 03, 2012 |